Metformin: 50 years old, fit as a fiddle, and indispensable for its pivotal role in type 2 diabetes management

被引：19

作者：

Halimi, S. ^{[1
]}

机构：

[1] CHU Grenoble, Dept Endocrinol Diabet Studies & Nutr, DUNE, F-38043 Grenoble, France

来源：

DIABETES & METABOLISM | 2006年 / 32卷 / 06期

关键词：

D O I：

10.1016/S1262-3636(07)70309-9

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：555 / 556

页数：2

共 12 条

[1] Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes inadequately controlled with metformin alone [J].

Charbonnel, Bernard ;

Karasik, Avraham ;

Liu, Ji ;

Wu, Mei ;

Meininger, Gary .

DIABETES CARE, 2006, 29 (12) :2638-2643

[2] Initiating oral glucose-lowering therapy with metformin in type 2 diabetic patients: an evidence-based strategy to reduce the burden of late-developing diabetes complications [J].

Consoli, A ;

Gomis, R ;

Halimi, S ;

Home, P ;

Mehnert, H ;

Strojek, K ;

Van Gaal, LF .

DIABETES & METABOLISM, 2004, 30 (06) :509-516

[3]

DeFronzo RA, 1996, NEW ENGL J MED, V334, P269

[4] One-year glycemic control with a sulfonylurea plus pioglitazone versus a sulfonylurea plus metformin in patients with type 2 diabetes [J].

Hanefeld, M ;

Brunetti, P ;

Schernthaner, GH ;

Matthews, DR ;

Charbonnel, BH .

DIABETES CARE, 2004, 27 (01) :141-147

[5] Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy [J].

Kahn, Steven E. ;

Haffner, Steven M. ;

Heise, Mark A. ;

Herman, William H. ;

Holman, Rury R. ;

Jones, Nigel P. ;

Kravitz, Barbara G. ;

Lachin, John M. ;

O'Neill, M. Colleen ;

Zinman, Bernard ;

Viberti, Giancarlo .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (23) :2427-2443

[6] ROLE OF METFORMIN ACCUMULATION IN METFORMIN-ASSOCIATED LACTIC-ACIDOSIS [J].

LALAU, JD ;

LACROIX, C ;

COMPAGNON, P ;

DECAGNY, B ;

RIGAUD, JP ;

BLEICHNER, G ;

CHAUVEAU, P ;

DULBECCO, P ;

GUERIN, C ;

HAEGY, JM ;

LOIRAT, P ;

MARCHAND, B ;

RAVAUD, Y ;

WEYNE, P ;

FOURNIER, A .

DIABETES CARE, 1995, 18 (06) :779-784

[7] Utilisation of antihyperglycaemic drugs in ten European countries:: different developments and different levels [J].

Melander, A. ;

Folino-Gallo, P. ;

Walley, T. ;

Schwabe, U. ;

Groop, P. -H. ;

Klaukka, T. ;

Vallano, A. ;

Laporte, J. -R. ;

Gallego, M. R. ;

Schiappa, M. ;

Roder, M. ;

Kampmann, J. P. ;

de Swaef, A. ;

Aberg, M. ;

Mansson, N. -O. ;

Lindblad, U. .

DIABETOLOGIA, 2006, 49 (09) :2024-2029

[8] Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy - A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes [J].

Nathan, David M. ;

Buse, John B. ;

Davidson, Mayer B. ;

Heine, Robert J. ;

Holman, Rury R. ;

Sherwin, Robert ;

Zinman, Bernard .

DIABETES CARE, 2006, 29 (08) :1963-1972

[9] Triple therapy in type 2 diabetes - Insulin glargine or rosiglitazone added to combmiation therapy of sulfonylurea plus metformin in insulin-naive patients [J].

Rosenstock, J ;

Sugimoto, D ;

Strange, P ;

Stewart, JA ;

Soltes-Rak, E ;

Dailey, G .

DIABETES CARE, 2006, 29 (03) :554-559

[10] Efficacy and safety of pioglitazone versus metformin in patients with type 2 diabetes mellitus:: A double-blind, randomized trial [J].

Schernthaner, G ;

Matthews, DR ;

Charbonnel, B ;

Hanefeld, M ;

Brunetti, P .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (12) :6068-6076

← 1 2 →